Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study

被引:4
作者
Hikasa, Shinichi [1 ]
Shimabukuro, Shota [1 ]
Hideta, Kyoko [1 ]
Higasa, Satoshi [2 ]
Sawada, Akihiro [2 ]
Tokugawa, Tazuko [2 ]
Tanaka, Kuniyoshi [1 ]
Yanai, Mina [1 ]
Kimura, Takeshi [1 ]
机构
[1] Hosp Hyogo Coll Med, Dept Pharm, Nishinomiya, Hyogo, Japan
[2] Hyogo Coll Med, Div Hematol, Dept Internal Med, Nishinomiya, Hyogo, Japan
关键词
Antiretroviral therapy; toxicity; HIV; AIDS; CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; INJURY MOLECULE-1; CLINICAL MARKER; CYSTATIN C; NEPHROPATHY; PERFORMANCE; PROGRESSION; MORTALITY; EXCRETION;
D O I
10.1177/0956462418788432
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Renal dysfunction is recognized with increasing frequency among the non-infectious co-morbidities associated with human immunodeficiency virus (HIV) infection. Recently, urinary liver-type fatty acid-binding protein (L-FABP) was suggested to be a predictor of the progression of renal dysfunction in patients without HIV. However, little is known regarding the utility of urinary L-FABP as a predictor of renal dysfunction in patients with HIV. A retrospective, observational, single-centre study was conducted between July 2014 and December 2016. The primary outcome was renal dysfunction defined as decrease in estimated glomerular filtration rate to less than 60 ml/min/1.73 m(2). To estimate the effect of urinary L-FABP, proteinuria category, and urinary beta 2 microglobulin (beta 2MG) on the time to the first event, a log-rank test was performed. Accuracy, determined by area under the curve and calculated from receiver operating characteristic curves, was also assessed. Thirty Japanese outpatients with HIV receiving antiretroviral therapy (ART) were enrolled. The primary outcome occurred in five patients during the follow-up period. Urinary L-FABP level and proteinuria category were significantly associated with renal dysfunction (p = 0.045 and p = 0.037, respectively). In contrast, urinary beta 2MG level was not significantly associated with renal dysfunction (p = 0.141). Urinary L-FABP was the most accurate predictor of renal dysfunction among the three urinary parameters. In conclusion, urinary L-FABP levels in HIV patients receiving ART were more accurate for predicting renal dysfunction than proteinuria and urinary beta 2MG. In addition, urinary L-FABP helped to discriminate those patients with a higher risk for renal dysfunction.
引用
收藏
页码:1424 / 1431
页数:8
相关论文
共 46 条
[1]   Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus [J].
Ahn, Kang Hee ;
Kim, Sang Soo ;
Kim, Won Jin ;
Kim, Jong Ho ;
Nam, Yun Jeong ;
Park, Su Bin ;
Jeon, Yun Kyung ;
Kim, Bo Hyun ;
Kim, In Joo ;
Kim, Yong Ki .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (05) :875-882
[2]   How to manage HIV-infected patients with chronic kidney disease in the HAART era [J].
Ando, Minoru ;
Tsuchiya, Ken ;
Nitta, Kosaku .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (03) :363-372
[3]   Predictive Effects of Urinary Liver-Type Fatty Acid-Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy [J].
Araki, Shin-ichi ;
Haneda, Masakazu ;
Koya, Daisuke ;
Sugaya, Takeshi ;
Isshiki, Keiji ;
Kume, Shinji ;
Kashiwagi, Atsunori ;
Uzu, Takashi ;
Maegawa, Hiroshi .
DIABETES CARE, 2013, 36 (05) :1248-1253
[4]   HIV and kidney diseases: 35 years of history and consequences [J].
Campos, Pedro ;
Ortiz, Alberto ;
Soto, Karina .
CLINICAL KIDNEY JOURNAL, 2016, 9 (06) :772-781
[6]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305
[7]  
Gupta SK, 2004, CLIN NEPHROL, V61, P1
[8]   Utility of estimated glomerular filtration rate based on cystatin C in patients receiving combination antiretroviral therapy including dolutegravir [J].
Hikasa, Shinichi ;
Hideta, Kyoko ;
Shimabukuro, Shota ;
Higasa, Satoshi ;
Sawada, Akihiro ;
Tokugawa, Tazuko ;
Kimura, Takeshi .
INFECTIOUS DISEASES, 2018, 50 (01) :77-79
[9]   The association between urinary liver-type fatty acid-binding protein and chronic kidney disease classification in HIV-infected Japanese patients [J].
Hikasa, Shinichi ;
Yasuda, Megumi ;
Hideta, Kyoko ;
Kawakami, Mai ;
Higasa, Satoshi ;
Sawada, Akihiro ;
Tokugawa, Tazuko ;
Kimura, Takeshi .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (06) :971-977
[10]   Performance of GFR equations in Japanese subjects [J].
Horio, Masaru ;
Imai, Enyu ;
Yasuda, Yoshinari ;
Watanabe, Tsuyoshi ;
Matsuo, Seiichi .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (03) :352-358